Medicare Enrolled
Dr. Kalpesh Patel, M.D.
Neurology · Albany, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Kalpesh Patel is a neurology specialist in Albany, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 19,487 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $12,352 from 60 pharmaceutical and/or device companies across 715 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 4% volume in GA
$12,352 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗19,487
Medicare services
Top 4% in GA for neurology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
16,395 | $5 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,711 | $60 | $119 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
470 | $40 | $109 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
253 | $81 | $150 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
239 | $0 | $21 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
105 | $10 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $117 | $290 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
64 | $110 | $459 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
64 | $72 | $354 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
31 | $9 | $55 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $52 | $140 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
24 | $143 | $1,089 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $78 | $250 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
17 | $42 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,352
Total received (2018-2024)
Avg $1,765/year across 7 years
Top 22% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
715
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,425
2023
$1,547
2022
$1,781
2021
$1,822
2020
$1,501
2019
$1,802
2018
$2,473
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$174
Lilly USA, LLC
$173
Neurocrine Biosciences, Inc.
$158
Biogen, Inc.
$147
Alexion Pharmaceuticals, Inc.
$104
ABBVIE INC.
$97
Lundbeck LLC
$82
SK Life Science, Inc.
$80
Sumitomo Pharma America, Inc.
$63
CATALYST PHARMACEUTICALS, INC.
$58
Teva Pharmaceuticals USA, Inc.
$50
ARGENX US, INC.
$45
UCB, Inc.
$40
Genentech USA, Inc.
$32
PFIZER INC.
$25
TG Therapeutics, Inc.
$24
CSL Behring
$23
JAZZ PHARMACEUTICALS INC.
$17
EMD Serono, Inc.
$17
Eisai Inc.
$17
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$1,527
Novartis Pharmaceuticals Corporation
$1,186
UCB, Inc.
$1,022
Biogen, Inc.
$942
Neurocrine Biosciences, Inc.
$655
Lilly USA, LLC
$629
EMD Serono, Inc.
$596
SK Life Science, Inc.
$435
GENZYME CORPORATION
$419
Alexion Pharmaceuticals, Inc.
$359
Sunovion Pharmaceuticals Inc.
$346
Eisai Inc.
$344
Amgen Inc.
$330
Avanir Pharmaceuticals, Inc.
$303
Genentech USA, Inc.
$286
EISAI INC.
$273
Teva Pharmaceuticals USA, Inc.
$226
Sumitomo Pharma America, Inc.
$213
Greenwich Biosciences, Inc.
$205
ABBVIE INC.
$167
PFIZER INC.
$136
Upsher-Smith Laboratories LLC
$132
Lundbeck LLC
$102
Genentech, Inc.
$100
Biohaven Pharmaceuticals, Inc.
$96
Biohaven Pharmaceutical Holding Company Ltd.
$95
Adamas Pharmaceuticals, Inc.
$84
ARGENX US, INC.
$83
UPSHER-SMITH LABORATORIES LLC
$73
Allergan, Inc.
$69
ACADIA Pharmaceuticals Inc
$69
LivaNova USA, Inc.
$68
JAZZ PHARMACEUTICALS INC.
$59
CATALYST PHARMACEUTICALS, INC.
$58
MITSUBISHI TANABE PHARMA AMERICA, INC.
$58
IMPEL PHARMACEUTICALS INC.
$50
Janssen Pharmaceuticals, Inc
$49
Kyowa Kirin, Inc.
$39
Mitsubishi Tanabe Pharma America, Inc.
$32
Chiesi USA, Inc.
$30
SCILEX PHARMACEUTICALS INC.
$29
Amneal Pharmaceuticals LLC
$28
Catalyst Pharmaceuticals, Inc.
$25
AbbVie, Inc.
$25
TG Therapeutics, Inc.
$24
CSL Behring
$23
Merz Pharmaceuticals, LLC
$23
Azurity Pharmaceuticals, Inc.
$23
AbbVie Inc.
$22
Promius Pharma LLC
$21
VBI Vaccines (Delaware) Inc.
$21
Banner Life Sciences, LLC
$21
Vanda Pharmaceuticals Inc.
$21
Neurelis, Inc.
$17
US WorldMeds, LLC
$16
Allergan Inc.
$15
Acorda Therapeutics, Inc
$13
Mallinckrodt Hospital Products Inc.
$13
Assertio Therapeutics, Inc.
$11
Corium, LLC
$11
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · CLEVIPREX · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Eprontia · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Gralise · HETLIOZ · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · ONGENTYS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · PreHevbrio · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVGART · Vimpat · Xeomin · ZEMBRACE SYMTOUCH · ZTLido · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
5
County median income
$46,784
Nearest hospital to ZIP centroid (approximate)
PHOEBE WORTH MEDICAL CENTER
15.6 mi
15.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 4% in GA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Patel performed 16,395 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $12,352 from 60 companies across 715 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologists in Albany?
Dr. Patel's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Albany
Browse neurologists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology